Target intelligence / Profile preview

DLGAP1 antisense RNA 6 (DLGAP1-AS6)

Target: DLGAP1-AS6
Molecular classification: Long non-coding RNA (lncRNA), Other (non-protein-coding RNA)

Overview

DLGAP1 antisense RNA 6 (DLGAP1-AS6) is a long non-coding RNA (lncRNA) gene annotated in the human genome, also known as RP11-874J12.4. It does not encode a protein, and its function is currently uncharacterized in the published biomedical literature. Unlike other DLGAP1 antisense lncRNAs such as DLGAP1-AS1 and DLGAP1-AS2, which have established roles in tumor progression and may have therapeutic or prognostic relevance, no experimental studies have linked DLGAP1-AS6 to specific biological processes, disease mechanisms, or utility as a clinical biomarker or drug target[3][1][2].

Other names: RP11-874J12.4DLGAP1-AS6

Beyond the preview

Go deeper on DLGAP1 antisense RNA 6 (DLGAP1-AS6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DLGAP1 antisense RNA 6 (DLGAP1-AS6).

Explore the full profile